Stifel initiated coverage on Equillium with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for EQ
Across the 5 sessions after earlier EQ headlines, the stock closed higher 1 times and lower 3 times, with a median move of 6.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | EQ | SPY |
|---|---|---|---|
| Feb 3, 2026 | Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | +0.0% | -0.8% |
| Nov 21, 2025 | Equillium to Participate in Upcoming Investor Conferences | -5.0% | +1.0% |
| Nov 14, 2025 | Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update | +23.8% | -0.0% |
| Nov 4, 2025 | Equillium to Participate in Upcoming Investor Conferencesand 1 other headline that session | -7.1% | -1.2% |
| Oct 22, 2025 | Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 | -6.5% | -0.5% |
Quantisnow market dataNASDAQ
EQ
Equillium Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for EQ
Full EQ profile on Quantisnow Follow EQ and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time